SCHEMBL4534986

SCHEMBL4534986

COc1ccc(Cn2cnc3c(NCCc4cc5cccc(Cl)c5c(C=O)n4)ncnc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HTT P42858 3/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 1/20 0.41
TP53 P04637 2/20 0.41
HDAC2 Q92769 1/20 0.41
TMIGD3 P0DMS9 2/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
ADORA2B P29275 1/20 0.41
YTHDC1 Q96MU7 1/20 0.41
CTSL P07711 2/20 0.40
FGFR1 P11362 1/20 0.40
FGFR2 P21802 1/20 0.40
FGFR4 P22455 1/20 0.40
FGFR3 P22607 1/20 0.40
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4539184 0.92 HDAC1 (0.43) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL4542862 0.89 HTT (0.45) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL4530998 0.87 HDAC1 (0.47) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL4539338 0.86 CTSL (0.47) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL4542188 0.84 HDAC1 (0.43) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL4533401 0.84 HDAC1 (0.46) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL4541032 0.84 MAPT (0.47) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL3699542 0.83 HDAC1 (0.44) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL3699543 0.83 HDAC1 (0.44) HDAC1HDAC6HTTMAPTHPGD
SCHEMBL4564684 0.83 HDAC1 (0.42) HDAC1HDAC6HTTMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed